Financial statements Max-Pharma

Balance sheet of Max-Pharma

Company age:
Age:
9 y. 9 m. 4 d.
Share capital:
Share capital:
5 000 PLN
Profit and loss statement Balance Cash flow Profitability

Balance sheet data of MAX-PHARMA

Year
2018
2019
2020
2021
2022
2023
Total assets 38 601 914,82 37 165 854,54 32 506 345,93 32 718 773,46 34 196 163,66 22 846 801,91
A. Fixed assets 23 628 818,65 22 018 825,94 19 602 107,15 19 070 477,91 18 248 147,60 4 246 018,17
B. Current assets 14 973 096,17 15 147 028,60 12 904 238,78 13 648 295,55 15 948 016,06 18 600 783,74
C. Share capital contributions (basic funds) - - - - - -
D. Own shares (stocks) - - - - - -
Total liabilities 38 601 914,82 37 165 854,54 32 506 345,93 32 718 773,46 34 196 163,66 22 846 801,91
A. Equity -14 426 111,66 -18 499 971,94 -25 031 597,28 -29 000 760,75 -31 605 642,87 -39 583 244,28
B. Liabilities and provisions for liabilities 53 028 026,48 55 665 826,48 57 537 943,21 61 719 534,21 65 801 806,53 62 430 046,19
I. Long-term liabilities - - - - - -
II. Short-term liabilities 51 978 794,15 54 499 431,02 55 035 850,88 58 965 009,66 62 694 808,15 58 346 256,71
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.